| Model Number |
MM0020 |
| Medical Device Problem Codes |
Off-Label Use (1494); Use of Device Problem (1670); Improper or Incorrect Procedure or Method (2017)
|
| Health Effect - Clinical Codes |
Itching Sensation (1943); Rash (2033)
|
| Date of Event |
04/23/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
This mdr is being submitted due to the stated reaction experienced by the patient after a mixture of acell's micromatrix powder reconstituted with 0.9% bacteriostatic sodium chloride was injected into the scalp for treatment of alopecia and the subsequent medical intervention required to relieve her symptoms.A review of the manufacturing records for this lot identified no deviations in the production process that fall outside of specification.The device was manufactured and distributed sterile in compliance with fda, state and local laws and regulations and acell's operating procedures.There has been biocompatibility testing performed per iso10993 on acell's micromatrix product line which has demonstrated micromatrix does not cause adverse responses in test subjects.The use of this product for hair loss treatment is off label and not recommended or promoted by acell, inc.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2019 acell received notification from a nurse that a patient developed a rash, nodules under skin at some injection sites and severe itching after a hair restoration procedure with micromatrix diluted with 0.9% bacteriostatic sodium chloride.The procedure was done on (b)(6) 2019 and the patient reported the adverse reactions started on (b)(6) 2019.Benadryl provided little relief and on (b)(6) 2019 the patient was prescribed prednisone (60mg on day one, 40mg for 5 days).The patient was last seen on (b)(6) 2019, and as of (b)(6) 2019 is doing better as prednisone provided some relief.
|
| |
|
Search Alerts/Recalls
|